Test Name Methylphenidate and Metabolite Screen, Urine
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80307
New York State Approval Status
Approved
Turnaround Time
7 days (If Positive: 14 days)
Test Includes
1
Methylphenidate
Ritalin®
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
ng/mL
10
Stimulant
2
Ritalinic Acid
Methylphenidate Metabolite
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
ng/mL
50
Stimulant
Test Also Known As
Concerta® Focalin; Methidate®
Reflex Tests
Test Code
Test Name
5132U
Methylphenidate and Metabolite Confirmation, Urine
Compliance Statement
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
9193U Methylphenidate and Metabolite Screen, Urine - Current Version
Analyte
Units
Analyte Mapping Code
LOINC®
Methylphenidate
ng/mL
METHYLPHEN
19577-6
Ritalinic Acid
ng/mL
RITALINAC
5132U Methylphenidate and Metabolite Confirmation, Urine - Current Version
Analyte
LOINC®
Methylphenidate
20548-4
Ritalinic Acid
Some LOINC® codes may not have been assigned or are not available.
This material contains content from LOINC (http://loinc.org). LOINC is copyright ® 1995-2023, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc.